Identification of genetic loci for basal cell nevus syndrome and inflammatory bowel disease in a single large pedigree |
| |
| Authors: | Carolien I. Panhuysen Amir Karban Alisa Knodle Manning Theodore M. Bayless Richard H. Duerr Joan E. Bailey-Wilson Ervin H. Epstein Jr. Steven R. Brant |
| |
| Affiliation: | (1) Genetics Program, Department of Medicine, Boston University School of Medicine, Boston, MA, USA;(2) Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA;(3) Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, The School of Medicine, Johns Hopkins University, Baltimore, MD, USA;(4) Department of Gastroenterology, Rambam Medical Center, Haifa, Israel;(5) Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA;(6) National Human Genome Research Institute, National Institutes of Health, Baltimore, MD, USA;(7) Department of Dermatology, University of California San Francisco, San Francisco, CA, USA;(8) Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA;(9) JHUSOM, 1503, E. Jefferson Street, Baltimore, MD 21231, USA |
| |
| Abstract: | Basal Cell Nevus Syndrome (BCNS) is an autosomal dominant disease. PTCH1 gene mutations have been found responsible in many but not all pedigrees. Inflammatory Bowel Disease (IBD) is a complex genetic disorder, disproportionate in Ashkenazim, and characterized by chronic intestinal inflammation. We revisited a large Ashkenazim pedigree, first reported in 1968, with multiple diagnoses of BCNS and IBD, and with a common genetic cause for both disorders proposed. We expanded the pedigree to four generations and performed a genome-wide linkage study for BCNS and IBD traits. Twelve members with BCNS, seven with IBD, five with both diagnoses and eight unaffected were genotyped. Both non-parametric (GENEHUNTER 2.1) and parametric (FASTLINK) linkage analyses were performed and a validation through simulation was performed. BCNS linked to chromosome 9q22 (D9S1120) just proximal to the PTCH1 gene (NPL=3.26, P=0.003; parametric two-point LOD=2.4, parametric multipoint LOD=3.7). Novel IBD linkage evidence was observed at chromosome 1p13 (D1S420, NPL 3.92, P=0.0047; parametric two-point LOD=1.9). Linkage evidence was also observed to previously reported IBD loci on 4q, (D4S2623, NPL 3.02, P=0.012; parametric two-point LOD=2.15), 10q23 (D10S1225 near DLG5, NPL 3.33, P=0.0085; parametric two-point LOD=1.3), 12 overlapping the IBD2 locus (D12S313, NPL 2.6, P=0.018; parametric two-point LOD=1.52), and 7q (D7S510 and D7S3046, NPL 4.06, P=0.0035; parametric two-point LOD=2.18). In this pedigree affected by both BCNS and IBD, the two traits and their respective candidate genetic loci segregate independently; BCNS maps to the PTCH1 gene and IBD maps to several candidate regions, mostly overlapping previously observed IBD loci.Electronic Supplementary Material Supplementary material is available for this article at and is accessible for authorized users.Carolien I. Panhuysen and Amir Karban contributed equally to this work |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
